The evolution of clot strength in critically ill COVID-19 patients: a prospective observational thromboelastography study

Thrombosis Journal

Suhail Sarwar Siddiqui¹  Syed Nabeel Muzaffar¹  Afzal Azim²  Nilanchal Chakraborty³ 

[1] Department of Critical Care Medicine, King George’s Medical University, 226003, Lucknow, Uttar Pradesh, India;Department of Critical Care Medicine, Sanjay Gandhi Postgraduate Institute of Medical Sciences (SGPGIMS), 226014, Lucknow, Uttar Pradesh, India;Institute of Neurosciences, Kolkata, India;

关键词: Thromboelastography (TEG);    COVID-19;    Hypercoagulability;    fibrinolysis;   

DOI  :  10.1186/s12959-022-00365-3

来源: Springer

【 摘 要 】

The authors have done commendable work in exploring the utility of a comprehensive viscoelastic test for assessment of the coagulation cascade in Coronavirus disease 2019 (COVID-19) patients. This article published in your esteemed journal in November 2021 “The evolution of clot strength in critically-ill COVID-19 patients: a prospective observational thromboelastography study” found hypercoagulability in most of the patients at Intensive Care Unit (ICU) admission and also noted a persistently increased fibrin contribution to clot strength. However, we would like to comment upon a few points which may be of importance to the readers.

【 授权许可】

CC BY